DE1484727U - - Google Patents

Info

Publication number
DE1484727U
DE1484727U DENDAT1484727D DE1484727DU DE1484727U DE 1484727 U DE1484727 U DE 1484727U DE NDAT1484727 D DENDAT1484727 D DE NDAT1484727D DE 1484727D U DE1484727D U DE 1484727DU DE 1484727 U DE1484727 U DE 1484727U
Authority
DE
Germany
Prior art keywords
ttt
mmt
tmt
iii
ttttt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1484727D
Other languages
German (de)
English (en)
Publication of DE1484727U publication Critical patent/DE1484727U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1484727D Active DE1484727U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1484727U true DE1484727U (OSRAM)

Family

ID=789914

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1484727D Active DE1484727U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1484727U (OSRAM)

Similar Documents

Publication Publication Date Title
Yuan et al. Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
Rini et al. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
Deraco et al. Consensus statement on peritoneal mesothelioma
BRPI0516407A (pt) agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
Augenstein et al. CeDAR: Carolinas equation for determining associated risks
Scarpa et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease.
US20200299774A1 (en) Molecular profiling for cancer
MX2021015328A (es) Agonistas del receptor del peptido-1 similar al glucagon.
Krieg et al. CXCR4-A prognostic and clinicopathological biomarker for pancreatic ductal adenocarcinoma: A Meta-Analysis
US20090191559A1 (en) Her2 diagnostic methods
Davis et al. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer
DE1484727U (OSRAM)
Desantis et al. PROTACs bearing piperazine-containing linkers: what effect on their protonation state?
CA2657324A1 (en) Methods for making cancer prognoses based on subcellular localization of biomarkers
Clarke et al. Quantification of tissue shrinkage in canine small intestinal specimens after resection and fixation
CN102713606A (zh) 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法
Price et al. Current opinion on optimal treatment for colorectal cancer
Protic et al. Prognostic effect of ultra-staging node-negative colon cancer without adjuvant chemotherapy: a prospective National Cancer Institute-sponsored clinical trial
Li et al. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
Liu et al. Discovery of a meisoindigo-derived protac as the ATM degrader: Revolutionizing colorectal cancer therapy via synthetic lethality with ATR inhibitors
Ballent et al. Intestinal drug transport: ex vivo evaluation of the interactions between ABC transporters and anthelmintic molecules
Tejpar et al. Integrating biomarkers in colorectal cancer trials in the West and China
Beier et al. Production and characterization of monoclonal antibodies against the antibiotic tilmicosin
Bujanda et al. Colorectal cancer in a second round after a negative faecal immunochemical test
Kimura et al. Weak Points of a Stapled Side-to-Side Anastomosis.